Skip to main content
Hagop Youssoufian, MD, Oncology, Boston, MA

HagopYoussoufianMD

Oncology • Boston, MA

Biotech Executive; Adjunct Professor

Join to view full profile

Dr. Youssoufian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Youssoufian's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteResidency, Hematology and Medical Oncology, 1987 - 1989
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1986
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 1983 - 1985
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 1983

Certifications & Licensure

  • TX State Medical License
    TX State Medical License Active through 2014
  • American Board of Medical Genetics and Genomics Clinical Genetics

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Dose Optimization of Duvelisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Selection of Regimen for the Dose-Expan...
    Hagop Youssoufian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Phase 1b Study of the Epichaperome Inhibitor PU-H71 Administered Orally with Ruxolitinib Continuation for the Treatment of Patients with Myelofibrosis
    Hagop Youssoufian, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Gadeta Appoints Scientific Advisory Board and Provides Business Update
    Gadeta Appoints Scientific Advisory Board and Provides Business UpdateOctober 20th, 2022
  • Bob Goeltz Bolts Unity Biotechnology to Become CFO at Arcus Biosciences; John Johnson Tapped for His Latest CEO Gig
    Bob Goeltz Bolts Unity Biotechnology to Become CFO at Arcus Biosciences; John Johnson Tapped for His Latest CEO GigJuly 10th, 2020
  • Chutes & Ladders—Biogen Executive Kress Takes over the Reins of Syntimmune
    Chutes & Ladders—Biogen Executive Kress Takes over the Reins of SyntimmuneJanuary 5th, 2018
  • Join now to see all

Grant Support

  • Medical Genetics Research Fellowship ProgramNational Institute Of General Medical Sciences2000
  • Phenotype Screens For Bone Marrow FailureNational Heart, Lung, And Blood Institute2000
  • Molecular Analysis Of Fanconi'S Anemia C ProteinNational Heart, Lung, And Blood Institute2000
  • Molecular Analysis Of Fanconis Anemia C ProteinNational Heart, Lung, And Blood Institute1997–1999
  • Molecular Analysis Of Fanconis Anemia C ProteinNational Heart, Lung, And Blood Institute1995–1996
  • Biogenesis Of The Red Cell Membrane And CytoskeletonNational Heart, Lung, And Blood Institute1991–1993
  • Biogenesis Of The Red Cell Membrane And CytoskeletonNational Heart, Lung, And Blood Institute1989–1991

Professional Memberships

Dr. Hagop Youssoufian, Dr. Hagop Youssoufian, MD, Dr. H Youssoufian